PTJ
RLYB icon

Paul Tudor Jones’s Rallybio RLYB Stock Holding History

Paul Tudor Jones’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,296
Closed -$13.9K – 3039
2024
Q2 		$13.9K Buy
+1,296
New +$17.6K ﹤0.01% 2249

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Paul Tudor Jones's RLYB Position: Q3 2024 in Review

Paul Tudor Jones sold out of Rallybio (RLYB) in Q3 2024, closing a stake of 1,296 shares — an estimated $13.9K sold.

Paul Tudor Jones first reported a position in RLYB in Q2 2024 and held it in 1 quarter. The position peaked at $13.9K in Q2 2024. 49 funds tracked by Wall St. Rank hold RLYB as of Q3 2024.

  • Paul Tudor Jones reported no remaining Rallybio position as of Q3 2024 after selling out during the quarter.
  • Paul Tudor Jones sold 1,296 Rallybio shares in Q3 2024, an estimated $13.9K.
  • Paul Tudor Jones first reported a position in Rallybio in Q2 2024 and held it in 1 quarter.
  • Paul Tudor Jones's Rallybio position peaked at $13.9K in Q2 2024.
  • 49 funds tracked by Wall St. Rank held Rallybio as of Q3 2024.

Based on Tudor Investment Corp's 13F filing for Q3 2024, filed 14 Nov 2024.